Home / Pharmacology / Enzyme-Linked Receptors / Receptor Tyrosine Kinases (RTKs) / Insulin and Insulin-like Receptors / Insulin and Insulin-like Receptor Inhibitors / NVP ADW 742

NVP ADW 742

Cat. No. 5247 Submit a Review Datasheet / COA / SDS
Pricing Availability   Qty
Description: ATP-competitive inhibitor of IGF1R
Chemical Name: 5-[3-(Phenylmethoxy)phenyl]-7-[trans-3-(1-pyrrolidinylmethyl)cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Purity: ≥99% (HPLC)
Datasheet
Citations
Reviews
Literature (2)
Pathways (1)
Biological Activity Technical Data Solubility Calculators Datasheets References

Biological Activity for NVP ADW 742

NVP ADW 742 is an ATP-competitive inhibitor of IGF1R (IC50 in the range of 0.1-0.2 μM). Also inhibits c-Kit kinase activity (IC50 in the range of 3-5 μM). Exhibits a synergistic effect with Imatinib (Cat. No. 5906), enhancing the sensitivity of multiple small cell lung cancer cell lines to the chemotherapeutics Etoposide (Cat. No. 1226) and Carboplatin (Cat. No. 2626).

Technical Data for NVP ADW 742

M. Wt 453.58
Formula C28H31N5O
Storage Store at -20°C
Purity ≥99% (HPLC)
CAS Number 475488-23-4
PubChem ID 9825149
InChI Key LSFLAQVDISHMNB-UHFFFAOYSA-N
Smiles NC1=NC=NC2=C1C(C4=CC(OCC5=CC=CC=C5)=CC=C4)=CN2[C@@H]3C[C@@H](CN6CCCC6)C3

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for NVP ADW 742

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 22.68 50
ethanol 4.54 10

Preparing Stock Solutions for NVP ADW 742

The following data is based on the product molecular weight 453.58. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.5 mM 4.41 mL 22.05 mL 44.09 mL
2.5 mM 0.88 mL 4.41 mL 8.82 mL
5 mM 0.44 mL 2.2 mL 4.41 mL
25 mM 0.09 mL 0.44 mL 0.88 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

References for NVP ADW 742

References are publications that support the biological activity of the product.

Warshamana-Greene et al (2005) The Ins-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy. Clin.Cancer Res. 11 1563 PMID: 15746061

Warshamana-Greene et al (2004) The Ins-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling. Mol.Cancer Ther. 3 527 PMID: 15141010

Zhou et al (2011) The Ins-like growth factor-I receptor kinase inhibitor NVP-ADW742 sensitizes medulloblastoma to the effects of chemotherapy. Oncol. Rep. 25 1565 PMID: 21455580

If you know of a relevant reference for NVP ADW 742, please let us know.

View Related Products by Target

View Related Products by Product Action

View all Insulin and Insulin-like Receptor Inhibitors

Keywords: NVP ADW 742, NVP ADW 742 supplier, NVPADW742, ATP, competitive, inhibitors, inhibits, of, IGF1, receptors, kinases, c-Kit, small, cell, lung, cancer, lines, SCLC, insulin-like, growth, factor-1, receptor, Insulin, and, Receptors, Insulin-like, 5247, Tocris Bioscience

Citations for NVP ADW 742

Citations are publications that use Tocris products.

Currently there are no citations for NVP ADW 742. Do you know of a great paper that uses NVP ADW 742 from Tocris? Please let us know.

Reviews for NVP ADW 742

There are currently no reviews for this product. Be the first to review NVP ADW 742 and earn rewards!

Have you used NVP ADW 742?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Peptides Involved in Appetite Modulation Scientific Review

Peptides Involved in Appetite Modulation Scientific Review

Written by Sonia Tucci, Lynsay Kobelis and Tim Kirkham, this review provides a synopsis of the increasing number of peptides that have been implicated in appetite regulation and energy homeostasis; putative roles of the major peptides are outlined and compounds available from Tocris are listed.

Angiogenesis in Cancer Poster

Angiogenesis in Cancer Poster

This poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.

Pathways for NVP ADW 742

Insulin Signaling Pathway

Insulin Signaling Pathway

Signaling through the insulin pathway is fundamental for the regulation of intracellular glucose levels. This pathway can become dysregulated in diabetes.